One need only glance at the numbers connected with Human Immunodeficiency Virus (HIV) to understand the necessity of HIV testing. The Centers for Disease Control and Prevention (CDC) estimate that 1.2 million Americans currently host HIV and 50,000 Americans become infected per year. Of those, one-fifth don't even realize what they're carrying! It quickly becomes obvious that HIV testing is imperative to correctly judge and answer this expanding problem. Informed citizens can proactively address HIV when it affects their lives, and-equally important-they will require preventative measures to safeguard the rest of the populace.
That brings us to the enterprise of Hiv testing itself. At present, the CDC recommends routine testing for anyone aged 13 to 64. Eventually, they'd prefer to see HIV testing become part-and-parcel of any screening or medical care encounter. Until then, it's your responsibility to voluntarily contribute with their growing knowledge base and your own personal peace of mind. For that, you will require facts; specifically, you will require facts about it, a groundbreaking option to traditional testing methodology. In what ways, you ask? Let's discover:
Most procedures, including rapid HIV testing, rely on antibody detection to ascertain results. An example (blood, plasma, oral fluid, and sometimes urine) is collected and subjected to a prepared solution. If you will find any HIV-specific antibodies in the sample, the test will display a confident result. Both traditional and rapid HIV tests consistently perform with 99% accuracy, and a confident be a consequence of either requires additional verification, usually an alternate test such as the Western Blot test.
Traditional HIV testing involves the Enzyme Immunoassay (EIA), a long technique requiring a vein-derived blood sample and specialized laboratory equipment. These tests require two visits: you to definitely administer pretest counseling and draw blood, and another to supply results and provide further counseling or referrals. The time between the two visits will require anywhere from a day or two to weeks predicated on various delays in shipping, laboratory protocol, or retesting. In comparison, rapid HIV testing is vastly more convenient. The whole procedure takes less than around 30 minutes and requires only 1 visit, including counseling.
Because most clients at Hiv testing receive negative test results, countless them can eliminate the necessity for another visit once they choose rapid HIV testing. This saves both client and the practitioner time and money. It's also a sad reality that lots of traditional HIV testing clients don't return for their test results at all. Rapid HIV testing neatly solves this dilemma with same-day, on-site results. Furthermore, those persons who test HIV-positive through rapid testing can receive immediate counseling in order to avoid possible transmission while they watch for confirmed results.
Rapid HIV testing is considerably cheaper, faster, and easier for STD clinics to perform, meaning they may treat regional patients more effectively and in greater numbers. As medical technology advances, this plays a part in a greater public perception of testing and furthers awareness of HIV infection and the necessity to combat it. Additionally it supplies a larger quantity of secondary testing options to vet positive reactions and ensure maximum reliability and precision.
May 07, 2019: Global Bi-Specific Antibodies Market is estimated to grow at a substantial CAGR in the forecast period as the scope, product types, and its applications are increasing across the globe.
On the other hand, there are factors that may hamper the growth of the market including regulatory trials, and production hurdles in bi-specific antibodies growth.Download sample Copy of This Report at: https://www.radiantinsights.com/research/global-bi-specific-antibodies-market-forecast-to-2022/request-sample Bi-Specific Antibodies Market may be explored by key therapeutic areas, mechanisms of action, and geography.
Bi-Specific Antibodies Market may be explored by key therapeutic areas as autoimmune disorders, oncology, eye disorders, inflammatory disorders, and others.
The factors that could be attributed to the growth include increasing occurrence of diseases such as lung cancer, prostate cancer, breast cancer, and cervical cancer, and rise in the awareness levels toward health.Browse Full Report With TOC @ https://www.radiantinsights.com/research/global-bi-specific-antibodies-market-forecast-to-2022 The key players contributing to the robust growth of the Bi-Specific Antibodies Market comprise Bayer AG, Amgen, Inc., ImmunGene, Inc., Dow Pharmaceutical Solutions, Merck & Co., Inc., Immunocore Limited, Novartis AG, F. Hoffmann-La Roche AG, and Pfizer, Inc.
These antibodies are of particular importance for patients who experience recurrence or resistance to drugs.According to the RNCOS report entitled “Global Bi-Specific Antibodies Market Forecast to 2022”, the Global Bi-Specific Antibodies Market is anticipated to witness a double digit growth during the forecast period.
Furthermore, the report also gives information related to the commercially available bi-specific antibody drugs.Moreover, few hindrances, such as production hurdles and regulatory challenges, which are slowing down the growth of the Global Bi-Specific Antibodies Market, have also been mentioned in the report.
Oral fluid testing is a method used to collect a saliva sample from a test subject and analyze it for the presence of hormones, drugs, antibodies or other molecules.
Oral Fluid Collection Device is used for collection and transportation of specimen to the laboratory for confirmatory analysis.And in our report the oral collection devices used for drug testing in the workplace, criminal justice, drug treatment and pain management markets are all included.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-oral-fluid-collection-devices-2019-2024-577The classification of Oral Fluid Collection Devices includes General Analysis Collection Devices and Genomic Analysis Collection Devices, and the sale proportion of General Analysis Collection Devices in 2018 is about 60%, and because of the lower price, the revenue proportion of General Analysis Collection Devices in 2018 is about 30%.According to this study, over the next five years the Oral Fluid Collection Devices market will register a 8.8% CAGR in terms of revenue, the global market size will reach US$ 204.1 million by 2024, from US$ 134 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in Oral Fluid Collection Devices business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of Oral Fluid Collection Devices market by product type, application, key manufacturers and key regions and countries.This study considers the Oral Fluid Collection Devices value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.General Analysis Collection DevicesGenomic Analysis Collection DevicesSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.Workplace TestingCriminal Justice TestingDisease TestingOthersThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeGermanyFranceUKItalyRussiaSpainMiddle East & AfricaEgyptSouth AfricaIsraelTurkeyGCC CountriesThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.OraSure TechnologiesAbbott LaboratoriesQuest DiagnosticsSarstedtNeogen CorporationSalimetricsOasis DiagnosticsImmunodiagnosticLin-Zhi InternationalCell ProjectsIn addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
It also analyzes key emerging trends and their impact on present and future development.Research objectivesTo study and analyze the global Oral Fluid Collection Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of Oral Fluid Collection Devices market by identifying its various subsegments.Focuses on the key global Oral Fluid Collection Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Oral Fluid Collection Devices with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of Oral Fluid Collection Devices submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @ https://www.grandresearchstore.com/manufacturing-and-construction/global-oral-fluid-collection-devices-2019-2024-577Table of content2019–2024 Global Oral Fluid Collection Devices Consumption Market Report1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global Oral Fluid Collection Devices Consumption 2014–20242.1.2 Oral Fluid Collection Devices Consumption CAGR by Region2.2 Oral Fluid Collection Devices Segment by Type2.2.1 General Analysis Collection Devices2.2.2 Genomic Analysis Collection Devices2.3 Oral Fluid Collection Devices Consumption by Type2.3.1 Global Oral Fluid Collection Devices Consumption Market Share by Type (2014–2019)2.3.2 Global Oral Fluid Collection Devices Revenue and Market Share by Type (2014–2019)2.3.3 Global Oral Fluid Collection Devices Sale Price by Type (2014–2019)2.4 Oral Fluid Collection Devices Segment by Application2.4.1 Workplace Testing2.4.2 Criminal Justice Testing2.4.3 Disease Testing2.4.4 Others2.5 Oral Fluid Collection Devices Consumption by Application2.5.1 Global Oral Fluid Collection Devices Consumption Market Share by Application (2014–2019)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
The study finds that efficacy of oral fluid for drug testing is being widely acknowledged on account of accuracy and precision of results.
Multiple applications, such as pain management, drug treatment, and DUID (driving under influence of drugs) or drug-impaired driving, entail use of rapid oral fluid screening devices for instant yet accurate results.
In addition, increasing number of hospital-based laboratories and independent laboratories are making use of rapid oral fluid screening devices to perform multimodal tests.Request for the Report Summary: https://www.factmr.com/report/2694/rapid-oral-fluid-screening-devices-marketAs per the research study, oral fluid serves as a viable medium for drug testing, on account of the convenience to collect and low risks of sample adulteration.
Results obtained via oral fluid offer better understanding of the impact of drug abuse and seamless evaluation of an individual’s behavioral changes.
the intentional usage of medications without prescriptions is emerging as a serious concern across the globe that can lead to devastating results.
The practice of prescription drug abuse rising at alarming rates and subsequent number of deaths in consequence of drug overdose is resulting in ever-increasing number of emergency room visits, which, in turn, is likely to significantly contribute to growth of rapid oral fluid screening devices market.Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=2694According to the research study, end-users are likely to opt for strips over swabs and cassettes, with global sales anticipated to exceed 11,400 thousand units in 2019.
According to the new market research report “Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) – Global Forecast to 2025″, published by MarketsandMarkets™, the Drug Screening Market is projected to reach USD 10.0 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period.Browse in-depth TOC on “Drug Screening Market”192 – Tables35 – Figures192 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773The rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches are the major factors driving the growth of this market.Services segment expected to grow at the highest CAGR during the forecast period.Based on service and product, the drug screening market is segmented into services and products.
Services segment accounted for the largest share of the market in 2019.
This segment is also expected to register the highest CAGR during the forecast period, mainly due to the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new service launches, and regulatory approvals, and geographic expansion of drug and alcohol testing laboratories.Analytical instruments are expected to dominate the drug screening products market in 2019.Based on the product, the Drug and Alcohol Testing Market is segmented into analytical instruments, rapid testing devices, and consumables.
In 2019, the analytical segment is expected to dominate the market.
Growing alcohol consumption and drunken driving cases, stringent government laws mandating drug and alcohol testing, and technological advancements in this market are some of the key factors driving the growth of the analytical instruments market.Based on the sample type, the oral fluid segment is projected to grow at the highest CAGR during the forecast period.By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples.
Among these, the oral fluid segment is expected to register the highest CAGR during the forecast period.
